CXCL2 combined with HVJ-E suppresses tumor growth and lung metastasis in breast cancer and enhances anti-PD-1 antibody therapy

Breast cancer has a high risk of metastasis; however, no effective treatment has been established. We developed a novel immunotherapy for breast cancer to enhance cytotoxic T lymphocytes against cancer cells using N1-type neutrophils with anti-tumor properties. For this purpose, we combined CXCL2 (C...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Yi Chun, Nishikawa, Tomoyuki, Chang, Chin Yang, Tai, Jiayu A., Kaneda, Yasufumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851488/
https://www.ncbi.nlm.nih.gov/pubmed/33575480
http://dx.doi.org/10.1016/j.omto.2020.12.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851488/
https://www.ncbi.nlm.nih.gov/pubmed/33575480
http://dx.doi.org/10.1016/j.omto.2020.12.011

Ejemplares similares